247 related articles for article (PubMed ID: 34445989)
1. Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study.
Zhang F; Liu Z; Liang J; Liu S; Wu K; Zhang F; Zhou C; Lu Y; Zhu Y; Wang X
BMC Cancer; 2021 Aug; 21(1):961. PubMed ID: 34445989
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Role of Ki-67 in Adrenocortical Carcinoma After Primary Resection: A Retrospective Mono-Institutional Study.
Zhang F; Zhang F; Liu Z; Wu K; Zhu Y; Lu Y
Adv Ther; 2019 Oct; 36(10):2756-2768. PubMed ID: 31471770
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes.
Margonis GA; Kim Y; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
Ann Surg Oncol; 2016 Jan; 23(1):134-41. PubMed ID: 26286195
[TBL] [Abstract][Full Text] [Related]
4. Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.
Kim Y; Margonis GA; Prescott JD; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem AI; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
JAMA Surg; 2016 Apr; 151(4):365-73. PubMed ID: 26676603
[TBL] [Abstract][Full Text] [Related]
5. Operative intervention for recurrence of adrenocortical carcinoma: A single-center experience.
Zhang F; Liu Z; Liang J; Tang Y; Liu S; Zhou C; Zhang F; Wu K; Lu Y; Wang X
Surgery; 2021 May; 169(5):1131-1138. PubMed ID: 33279225
[TBL] [Abstract][Full Text] [Related]
6. Resection of adrenocortical carcinoma liver metastasis: is it justified?
Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR
Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905
[TBL] [Abstract][Full Text] [Related]
7. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
[TBL] [Abstract][Full Text] [Related]
8. Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer.
Wu M; Pan Y; Jia Z; Wang Y; Yang N; Mu J; Zhou T; Guo Y; Jiang J; Cao X
Dis Markers; 2019; 2019():9060845. PubMed ID: 31781312
[TBL] [Abstract][Full Text] [Related]
9. Surgical resection of synchronously metastatic adrenocortical cancer.
Dy BM; Strajina V; Cayo AK; Richards ML; Farley DR; Grant CS; Harmsen WS; Evans DB; Grubbs EG; Bible KC; Young WF; Perrier ND; Que FG; Nagorney DM; Lee JE; Thompson GB
Ann Surg Oncol; 2015 Jan; 22(1):146-51. PubMed ID: 25092161
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum ferritin is an independent prognostic factor for liver cancer after hepatectomy.
Wu SJ; Zhang ZZ; Cheng NS; Xiong XZ; Yang L
Surg Oncol; 2019 Jun; 29():159-167. PubMed ID: 31196483
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.
Gharzai LA; Green MD; Griffith KA; Else T; Mayo CS; Hesseltine E; Spratt DE; Ben-Josef E; Sabolch A; Miller BS; Worden F; Giordano TJ; Hammer GD; Jolly S
J Clin Endocrinol Metab; 2019 Sep; 104(9):3743-3750. PubMed ID: 31220287
[TBL] [Abstract][Full Text] [Related]
12. Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma.
Sbiera S; Sbiera I; Ruggiero C; Doghman-Bouguerra M; Korpershoek E; de Krijger RR; Ettaieb H; Haak H; Volante M; Papotti M; Reimondo G; Terzolo M; Luconi M; Nesi G; Mannelli M; Libé R; Ragazzon B; Assié G; Bertherat J; Altieri B; Fadda G; Rogowski-Lehmann N; Reincke M; Beuschlein F; Fassnacht M; Lalli E
J Clin Endocrinol Metab; 2017 Sep; 102(9):3491-3498. PubMed ID: 28911143
[TBL] [Abstract][Full Text] [Related]
13. Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma.
Liu-Chittenden Y; Patel D; Gaskins K; Giordano TJ; Assie G; Bertherat J; Kebebew E
J Clin Endocrinol Metab; 2016 Sep; 101(9):3345-52. PubMed ID: 27336360
[TBL] [Abstract][Full Text] [Related]
14. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center.
Ayala-Ramirez M; Jasim S; Feng L; Ejaz S; Deniz F; Busaidy N; Waguespack SG; Naing A; Sircar K; Wood CG; Pagliaro L; Jimenez C; Vassilopoulou-Sellin R; Habra MA
Eur J Endocrinol; 2013 Dec; 169(6):891-899. PubMed ID: 24086089
[TBL] [Abstract][Full Text] [Related]
16. Operative intervention for recurrent adrenocortical cancer.
Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Possible Prognostic Markers for Patients Undergoing Resection of Adrenocortical Carcinoma.
de Jong MC; Mihai R; Khan S
World J Surg; 2021 Mar; 45(3):754-764. PubMed ID: 33221947
[TBL] [Abstract][Full Text] [Related]
18. Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence.
Amini N; Margonis GA; Kim Y; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
Ann Surg Oncol; 2016 Jan; 23(1):126-33. PubMed ID: 26282907
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study.
Libé R; Borget I; Ronchi CL; Zaggia B; Kroiss M; Kerkhofs T; Bertherat J; Volante M; Quinkler M; Chabre O; Bala M; Tabarin A; Beuschlein F; Vezzosi D; Deutschbein T; Borson-Chazot F; Hermsen I; Stell A; Fottner C; Leboulleux S; Hahner S; Mannelli M; Berruti A; Haak H; Terzolo M; Fassnacht M; Baudin E;
Ann Oncol; 2015 Oct; 26(10):2119-25. PubMed ID: 26392430
[TBL] [Abstract][Full Text] [Related]
20. Survival and prognostic factors for adrenocortical carcinoma: a single institution experience.
Loncar Z; Djukic V; Zivaljevic V; Pekmezovic T; Diklic A; Tatic S; Dundjerovic D; Olujic B; Slijepcevic N; Paunovic I
BMC Urol; 2015 May; 15():43. PubMed ID: 26013141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
